Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Nuvigil
(United States) [Available]Synonyms :
armodafinil
Class :
CNS Stimulant agents
Brand Name :
Nuvigil
(United States) [Available]Synonyms :
armodafinil
Class :
CNS Stimulant agents
Dosage Forms & Strengths
Tablet, Oral:
50 mg
150 mg
200 mg
250 mg
150 - 250
mg
Tablet
Oral
once a day
in the morning
150 - 250
mg
Tablet
Oral
once a day
in the morning
150
mg
Tablet
Oral
once a day
before starting the work shift
It may diminish the effect when combined with irinotecan liposomal by affecting CYP3A4 metabolism
CNS stimulants: they may increase the CNS stimulant effect of opioid drugs
CNS stimulants: they may increase the CNS stimulant effect of opioid drugs
CNS stimulants: they may increase the CNS stimulant effect of opioid drugs
CNS stimulants: they may increase the CNS stimulant effect of opioid drugs
CNS stimulants: they may increase the CNS stimulant effect of non-opioid drugs
CNS stimulants: they may increase the CNS stimulant effect of non-opioid drugs
CNS stimulants: they may increase the CNS stimulant effect of non-opioid drugs
CNS stimulants: they may increase the CNS stimulant effect of non-opioid drugs
CNS stimulants: they may increase the CNS stimulant effect of non-opioid drugs
may decrease the therapeutic effect when combined with iobenguane radiopharmaceutical products
may decrease the therapeutic effect when combined with iobenguane radiopharmaceutical products
may decrease the therapeutic effect when combined with iobenguane radiopharmaceutical products
It may diminish the effect when combined with lumateperone by affecting CYP3A4 metabolism
may decrease the therapeutic effect when combined with iobenguane radiopharmaceutical products
may decrease the therapeutic effect when combined with iobenguane radiopharmaceutical products
may decrease the therapeutic effect when combined with iobenguane radiopharmaceutical products
may decrease the therapeutic effect when combined with iobenguane radiopharmaceutical products
may decrease the therapeutic effect when combined with iobenguane radiopharmaceutical products
when both drugs are combined, there may be a decreased effect of cabozantinib by affecting hepatic or intestinal enzyme cyp3a4 metabolism
the effect of armodafinil is decreased by lorlatinib, by altering intestinal or hepatic CYP3A4 enzyme metabolism
when both drugs are combined, there may be an increased risk of adverse effects
CNS depressants increase the effect of orphenadrine
When dexrabeprazole and armodafinil is used together, this leads to reduction in the dexrabeprazole’s metabolism
When acetohexamide is used together with armodafinil, this lead to reduction in acetohexamide’s metabolism
When armodafinil is used together with norelgestromin, this leads to a rise in norelgestromin’s metabolism
armodafinil: it may decrease the therapeutic efficacy of etynodiol
the metabolism of digitoxin can be heightened when combined with armodafinil
when both drugs combine armodafinil will increase effect of ifosfamide by affecting the enzyme CYP3A4 metabolism.
when both drugs are combined, there may be an increased metabolism of alpelisib
they decrease the effect of each other by pharmacodynamic antagonism
they decrease the effect of each other by pharmacodynamic antagonism
they decrease the effect of each other by pharmacodynamic antagonism
they decrease the effect of each other by pharmacodynamic antagonism
they decrease the effect of each other by pharmacodynamic antagonism
metyrosine: they may increase the sedative effect of CNS stimulants
pegvisomant: they may increase the sedative effect of CNS stimulants
ramosetron: they may increase the sedative effect of CNS stimulants
opioid drugs: they may increase the sedative effect of CNS stimulants
opioid drugs: they may increase the sedative effect of CNS stimulants
opioid drugs: they may increase the sedative effect of CNS stimulants
opioid drugs: they may increase the sedative effect of CNS stimulants
When armodafinil is used together with lomitapide, this leads to an enhancement in lomitapide’s metabolism
when both drugs are combined, there may be an increased metabolism of vinblastine
when both drugs are combined, there may be an increased metabolism of paclitaxel
Frequency defined:
>10%
Headache
1% to 10%
Palpitation
Insomnia
Lack of concentration
Depression
Pain
Skin rash
Agitation
Anxiety
Contact dermatitis
Increase thirst
Dry Throat
Tremor
Fever
Postmarketing
Angioedema
Hepatotoxicity
Pregnancy consideration: Studies reported major congenital malformations following in utero exposure to armodafinil.
Lactation: Armodafinil can be excreted in breast milk.
Pregnancy category:
Patient information leaflet
Generic Name: Armodafinil
Pronounced: armodafinil
Why do we use armodafinil?
Armodafinil is used to treat sleep apnea, narcolepsy, and other conditions related to day time sleepiness.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
